BNP Paribas Financial Markets Has $580,000 Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

BNP Paribas Financial Markets cut its stake in shares of Simulations Plus, Inc. (NASDAQ:SLPFree Report) by 35.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,969 shares of the technology company’s stock after selling 6,982 shares during the period. BNP Paribas Financial Markets owned approximately 0.06% of Simulations Plus worth $580,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in SLP. Versor Investments LP bought a new stake in shares of Simulations Plus in the fourth quarter worth about $385,000. Bahl & Gaynor Inc. increased its holdings in shares of Simulations Plus by 32.4% in the fourth quarter. Bahl & Gaynor Inc. now owns 14,500 shares of the technology company’s stock worth $649,000 after acquiring an additional 3,550 shares in the last quarter. Illinois Municipal Retirement Fund increased its holdings in shares of Simulations Plus by 2.8% in the fourth quarter. Illinois Municipal Retirement Fund now owns 9,647 shares of the technology company’s stock worth $432,000 after acquiring an additional 263 shares in the last quarter. Canton Hathaway LLC increased its holdings in shares of Simulations Plus by 25.0% in the fourth quarter. Canton Hathaway LLC now owns 5,000 shares of the technology company’s stock worth $224,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Louisiana State Employees Retirement System bought a new stake in shares of Simulations Plus in the fourth quarter worth about $358,000. 78.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $45.95, for a total transaction of $919,000.00. Following the completion of the transaction, the director now directly owns 3,580,857 shares of the company’s stock, valued at $164,540,379.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $45.95, for a total transaction of $919,000.00. Following the completion of the transaction, the director now directly owns 3,580,857 shares of the company’s stock, valued at $164,540,379.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Daniel L. Weiner sold 3,250 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $48.31, for a total value of $157,007.50. Following the transaction, the director now directly owns 8,759 shares of the company’s stock, valued at $423,147.29. The disclosure for this sale can be found here. Insiders sold 43,750 shares of company stock valued at $1,899,808 over the last three months. Company insiders own 20.90% of the company’s stock.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $48.24 on Friday. Simulations Plus, Inc. has a 1 year low of $32.69 and a 1 year high of $52.69. The business has a 50-day moving average of $46.60 and a two-hundred day moving average of $42.96. The company has a market capitalization of $964.08 million, a P/E ratio of 91.02 and a beta of 0.68.

Simulations Plus (NASDAQ:SLPGet Free Report) last announced its quarterly earnings results on Wednesday, April 3rd. The technology company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.02. Simulations Plus had a return on equity of 7.95% and a net margin of 16.22%. The company had revenue of $18.31 million during the quarter, compared to the consensus estimate of $17.31 million. During the same period in the prior year, the company earned $0.20 earnings per share. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. On average, equities analysts anticipate that Simulations Plus, Inc. will post 0.67 EPS for the current fiscal year.

Simulations Plus Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, May 6th. Stockholders of record on Monday, April 29th were given a dividend of $0.06 per share. The ex-dividend date was Friday, April 26th. This represents a $0.24 annualized dividend and a dividend yield of 0.50%. Simulations Plus’s dividend payout ratio is currently 45.28%.

About Simulations Plus

(Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Featured Stories

Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLPFree Report).

Institutional Ownership by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.